What the company does
Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of solid tumors, including gastrointestinal adenocarcinoma; and BT-001, an oncolytic virus, which is in …
What the weekly tape is saying
TNG closed the latest completed week at 0.77 EUR. The 4-week return is -8.3% and the 12-week return is 2.8%. Trend Signal is inactive, Market Dynamics is 0.31. Setup signature: Risk-first tape with a 27/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.86 EUR
- Vs Trend Line
- -10.8%
- Fair Value
- 1.08 EUR
- Vs Fair Value
- -28.6%
- 52W High
- 1.50 EUR
- 52W Low
- 0.73 EUR
- Drawdown
- -48.7%
- Range Position
- 5.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- FR Healthcare
- Sector Rank
- 52 of 76
- Sector Percentile
- 32.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 48 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 14 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.31
- 4W MD Change
- 234.9%
- Relative Strength
- -22.49
- 4W RS Change
- -94.8%
- Expectation
- Negative
- Probability
- 39.82%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 137.4K
- 13W Average
- 228.3K
- 52W Average
- 546.3K
- Vs 13W
- 0.6x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.7%
- 52W Volatility
- 6.7%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 6.1% / -4.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 230.1M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.77 EUR | -2.7% | 0.86 EUR | 1.08 EUR | 0.31 | -22.49 | 137.4K | Off |
| 5 Jun 2026 | 0.79 EUR | -5.4% | 0.88 EUR | 1.08 EUR | 0.45 | -19.58 | 222.8K | Off |
| 29 May 2026 | 0.83 EUR | 0.6% | 0.89 EUR | 1.09 EUR | 0.39 | -14.98 | 168.7K | Off |
| 22 May 2026 | 0.83 EUR | -1.1% | 0.91 EUR | 1.10 EUR | 0.08 | -14.57 | 226.3K | Off |
| 15 May 2026 | 0.84 EUR | 7.6% | 0.93 EUR | 1.10 EUR | -0.23 | -11.54 | 368.4K | Off |
| 8 May 2026 | 0.78 EUR | 4.6% | 0.94 EUR | 1.11 EUR | -0.61 | -18.98 | 199.4K | Off |
| 1 May 2026 | 0.75 EUR | -1.5% | 0.96 EUR | 1.12 EUR | -0.81 | -22.30 | 184.6K | Off |
| 24 Apr 2026 | 0.76 EUR | -1.8% | 0.97 EUR | 1.12 EUR | -1.00 | -21.39 | 154.0K | Off |
| 17 Apr 2026 | 0.77 EUR | -1.5% | 0.98 EUR | 1.13 EUR | -1.09 | -22.34 | 202.7K | Off |
| 10 Apr 2026 | 0.78 EUR | 5.8% | 1.00 EUR | 1.14 EUR | -1.19 | -19.44 | 213.6K | Off |
| 3 Apr 2026 | 0.74 EUR | -1.3% | 1.01 EUR | 1.14 EUR | -1.23 | -20.95 | 195.0K | Off |
| 27 Mar 2026 | 0.75 EUR | 0.3% | 1.02 EUR | 1.15 EUR | -1.11 | -17.05 | 395.3K | Off |
| 20 Mar 2026 | 0.75 EUR | -4.1% | 1.04 EUR | 1.16 EUR | -1.04 | -16.70 | 299.3K | Off |
| 13 Mar 2026 | 0.78 EUR | -4.9% | 1.05 EUR | 1.17 EUR | -1.08 | -15.64 | 397.5K | Off |